Literature DB >> 17663185

Spectrophotometric determination of rosuvastatin calcium in tablets.

B Uyar1, M Celebier, S Altinoz.   

Abstract

Rosuvastatin calcium is a synthetic lipid lowering agent which is used in hypercholesterolemia. It is a selective and competitive inhibitor of HMG-CoA reductase. In this study a simple, rapid and reliable spectrophotometric method was developed for the determination of rosuvastatin calcium in pharmaceutical preparations. The solutions of standard and pharmaceutical samples were prepared in methanol. 243 nm was chosen for measuring absorbances of rosuvastatin calcium. The developed method was validated with respect to linearity range, limit of detection and quantitation, accuracy, precision, specificity and ruggudness. The linearity range of the method was 1.0-60.0 microg mL(-1). The limit of detection was 0.33 microg mL(-1). The developed and validated method was applied to the determination of rosuvastatin calcium in pharmaceutical preparations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17663185

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  2 in total

1.  Development and Validation of a Stability-Indicating RP-UPLC Method for Determination of Rosuvastatin and Related Substances in Pharmaceutical Dosage Form.

Authors:  Harshal Kanubhai Trivedi; Mukesh C Patel
Journal:  Sci Pharm       Date:  2012-03-26

2.  TLC-spectrodensitometric method for simultaneous determination of dapagliflozin and rosuvastatin in rabbit plasma: stability indicating assay and kinetic studies.

Authors:  Noha S Abbas; Sayed M Derayea; Mahmoud A Omar; Gamal A Saleh
Journal:  RSC Adv       Date:  2020-11-09       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.